Since CD192 (CCR2) is the cell surface receptor to MCP-1, the reduction in MCP-1 levels correlates to the rise of CD192 expressing circulating monocytes observed in this patient after two days of SCD treatment. Here, CD177 is linked to Schnyder corneal dystrophy.